Skip to Main
About Us: O'Donnell Brain Institute Banner - UT Southwestern, Dallas, TX

About Us

The Peter O’Donnell Jr. Brain Institute, established in 2015 with a generous donation from Edith and Peter O'Donnell Jr., is housed within UT Southwestern Medical Center, an internationally recognized academic institution renowned for its research, medical education, and patient care.

The O’Donnell Brain Institute is supported by a $1 billion campaign that fuels its commitment to advance brain research and clinical care. Our 2,100-plus faculty and staff tackle the most complex problems in the brain. The Institute supports multidisciplinary approaches through a variety of grant and scholar programs that provide funding, mentoring, education, and tools for researchers at all levels. We are committed to building partnerships among basic and clinical scientists to achieve our mission of providing the best patient care possible today while creating a future of better treatment and prevention through discovery and innovation.

O'Donnell Brain Institute Collaboration Structure graphic

What We Offer

Integrated Environment

Integrated Environment

Latest Technologies

Latest Technologies

Mentorship Support

Mentorship Support

A Mission that Spans Research, Education, & Clinical Care

We work to improve the lives of people with brain disease through:

  • Pioneering research in areas from Alzheimer’s disease to depression that leads directly to improved patient care.
  • High-quality education for tomorrow’s leaders, in a wide variety of areas. Our programs feature mentoring from our expert faculty and access to the latest technologies in brain research and care.
  • Exceptional clinical care that translates research to the bedside quickly. U.S. News and World Report ranks us among the top neurology and neurosurgery hospitals in the country.

To accomplish our mission, we empower exceptional faculty, trainees, and clinicians like  Marc Diamond, M.D., Eric Olson, Ph.D., Joseph Takahashi, Ph.D., and Carol Tamminga, M.D. – to pursue their passions.

Genevieve Konopka, Ph.D., wears a white mask and blue gloves while working in her lab

Molecular Pathways Important for Human Brain Evolution

Genevieve Konopka, Ph.D., investigates the molecular pathways important for human brain evolution that are also at risk in cognitive disorders such as autism and Alzheimer’s disease. Her lab uses a combination of human neurons, animal models, and primate comparative genomics to uncover human-specific, disease-relevant patterns of gene expression.

Konopka Lab

Bradley Lega, M.D. works in his lab

Electrophysiology of Human Memory

Bradley Lega, M.D., is co-director of UT Southwestern’s comprehensive epilepsy program and a national expert on the use of stereo EEG to locate the origin of epileptic seizures in the brain. His work examines direct recordings from patients to develop strategies that can improve memory function and restore memory for patients with brain injuries or tumors.

Lega Lab

Joseph Takahashi, Ph.D., looks into a microscope in his lab

Circadian Revelations

Joseph Takahashi, Ph.D., has pioneered the use of forward genetics and positional cloning in the mouse as a tool for discovery of genes underlying neurobiology and behavior. His discovery of the mouse and human clock genes led to a description of a conserved circadian clock mechanism in animals.

Takahashi Lab

Carol Tamminga, M.D.

The Biology of Psychoses

Carol Tamminga, M.D., leads the Division of Translational Neuroscience in Schizophrenia with the goal of understanding the pathophysiology of schizophrenia and related disorders. The group’s research explores how the brain makes a hallucination or a delusion, and is providing insight at the cellular and synaptic levels.

Tamminga Lab

Madhukar Trivedi, M.D., talks to a male patient who sits in a chair

Taking the Guesswork Out of Depression Treatment

Madhukar Trivedi, M.D., and his team focus on pharmacological, psychosocial, and nonpharmacological treatments for depression. Dr. Trivedi, Director of the Center for Depression Research and Clinical Care leads a national trial that has produced what scientists are calling the project’s flagship finding: a computer that can accurately predict whether an antidepressant will work based on a patient’s brain activity.

Trivedi Lab